FX.co ★ Cellectar Biosciences Inc Loss At -$21.58 Mln In Q1

Cellectar Biosciences Inc (CLRB) reported a net loss of $21.58 million for the first quarter.

The loss translates to $0.74 per share, compared to a net loss of $8.58 million or $0.76 per share in the same period last year.

Summary of Cellectar Biosciences Inc's Q1 earnings (GAAP):

- Net Loss: $21.58 million, up from $8.58 million last year

- EPS: -$0.74, compared to -$0.76 last year